首页> 外文期刊>Journal of biopharmaceutical statistics >Multiplicity issues for platform trials with a shared control arm
【24h】

Multiplicity issues for platform trials with a shared control arm

机译:Multiplicity issues for platform trials with a shared control arm

获取原文
获取原文并翻译 | 示例
           

摘要

Common control arm, and how they compare to the ones arisen from standard independent trials. We provide our views on some of the popular "myths" associated with such design, under the frequentist framework. It is found that platform trial generally performs quite well in terms of type I error rate, false discovery rate, and power. In most cases, these operating characteristics of a platform trial are comparable to or even better than running individual trials.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号